We are live on
!
Find out more
ANEB
Anebulo Pharmaceuticals
ANEB
ANEB
Delisted
ANEB was delisted on the 27th of February, 2026.
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
2L
1
22NW LP
Seattle,
Washington
| $23.8M | – | – | – |
|
| 2 |
MP
2
Mangrove Partners
Greenwich,
Connecticut
| $2.83M | -$53.7K | -7,840 | -2% |
|
| 3 |
LCM
3
Laurion Capital Management
New York
| $1.48M | -$37.1K | -5,417 | -2% |
|
| 4 |
IC
4
Ikarian Capital
Dallas,
Texas
| $1.23M | +$60.9K | +8,890 | +5% |
|
| 5 |
BFM
5
Boothbay Fund Management
New York
| $123K | – | – | – |
|
| 6 |
6
BlackRock
New York
| $53K | -$2.46K | -360 | -5% |
|
| 7 |
7
UBS Group
Zurich,
Switzerland
| $15K | +$10.8K | +1,576 | +272% |
|
| 8 |
TRCT
8
Tower Research Capital (TRC)
New York
| $5K | +$5.18K | +756 | New |
|
| 9 |
9
Osaic Holdings
Scottsdale,
Arizona
| – | -$3K | -500 | Closed |
|
| 10 |
10
Morgan Stanley
New York
| – | +$7 | +1 | +50% |
|